Efficacy and safety of iguratimod compared with placebo and salazosulfapyridine in active rheumatoid arthritis: A controlled, multicenter, double-blind, parallel-group study

Modern Rheumatology

Volumn 17, Issue 1, 2007, Pages 1-9

  Hara, Masako ^a   Abe, Tohru ^b   Sugawara, Sachiko ^a   Mizushima, Yutaka ^c   Hoshi, Keiko ^d   Irimajiri, Shoichiro ^e   Hashimoto, Hiroshi ^f   Yoshino, Shinichi ^g   Matsui, Nobuo ^h   Nobunaga, Masashi ⁱ   Nakano, Shigeyuki ^j  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^e KAWASAKI MUNICIPAL HOSPITAL   (Japan)

^f Juntendo University Hospital   (Japan)

^g NIPPON MEDICAL SCHOOL   (Japan)

^h Nagoya City Rehabilitation Center   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j OITA UNIVERSITY   (Japan)

more..

Author keywords

Controlled study; Iguratimod; Rheumatoid arthritis; Salazosulfapyridine

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IGURATIMOD; IMMUNOSUPPRESSIVE AGENT; PLACEBO; PREDNISOLONE; SALAZOSULFAPYRIDINE; ANTIRHEUMATIC AGENT; CHROMONE DERIVATIVE; SULFONAMIDE;

ABDOMINAL PAIN; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FISHER EXACT TEST; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; INTERSTITIAL PNEUMONIA; JAPAN; JAPANESE; JAUNDICE; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MELENA; MULTICENTER STUDY; NEUTROPENIA; PARALLEL DESIGN; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SIDE EFFECT; SKIN DISEASE; STOMACH ULCER; STOMATITIS; VOMITING; HOSPITALIZATION; MIDDLE AGED;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHROMONES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SULFASALAZINE; SULFONAMIDES;

EID: 34247593508     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-006-0542-y     Document Type: Article

References (19)

1. A Kawakami M Tsuboi S Urayama N Matsuoka S Yamasaki A Hida 1999 Inhibitory effect of a new anti-rheumatic drug T-614 on costimulatory molecule expression, cytokine production, and antigen presentation by synovial cells J Lab Clin Med 133 566-74 10360631 10.1016/ S0022-2143(99)90186-5 1:CAS:528:DyaK1MXjvFOmu70%3D
2. M Kohno Y Aikawa Y Tsubouchi A Hashiramoto R Yamada Y Kawahito 2001 Inhibitory effect of T-614 on tumor necrosis factor-α induced cytokine production and nuclear factor-kκB activation in cultured human synovial cells J Rheumatol 28 2591-6 11764202 1:CAS:528:DC%2BD38Xht12iuw%3D%3D
3. Y Aikawa M Yamamoto T Yamamoto K Morimoto K Tanaka 2002 An anti-rheumatic agent T-614 inhibits NF-kκB activation in LPS- and TNF-α-stimulated THP-1 cells without interfering with IkκBα degradation Inflamm Res 51 188-94 12058956 10.1007/ PL00000291 1:CAS:528:DC%2BD38XjtlWhtLc%3D
4. K Tanaka T Yamamoto Y Aikawa K Kizawa K Muramoto H Matsuno 2003 Inhibitory effects of an anti-rheumatic agent T-614 on immunoglobulin production by cultured B cells and rheumatoid synovial tissues engrafted in SCID mice Rheumatology (Oxf) 42 1365-71 10.1093/rheumatology/keg381 1:CAS:528:DC%2BD3sXos1antbY%3D
5. K Tanaka T Shimotori S Makino Y Aikawa T Inaba C Yoshida 1992 Pharmacological studies of the new antiinflammatory agent 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one. 1st communication: Antiinflammatory, analgesic and other related properties Arzneimittelforschung 42 935-44 1418059 1:CAS:528:DyaK38XlsVejs7c%3D
6. K Tanaka T Shimotori Y Taniguchi M Eguchi C Abe 1993 Pharmacological studies on T-614, a novel anti-inflammatory agent: Effect on type II collagen-induced arthritis in DBA/1J mice and spontaneous arthritis in MRL/l mice Int J Immunother 9 69-78 1:CAS:528:DyaK3sXmtFKqsLw%3D
7. JC Edwards G Cambridge 2001 Sustained improvement in rheumatoid arthritis following a protocol designed to delete B lymphocytes Rheumatology (Oxf) 40 201-11
8. S De Vita F Zaja S Sacco A Dde Candia R Fanin G Ferraccioli 2002 Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis; evidence for a pathogenetic role of B cells Arthritis Rheum 46 2029-33 12209504 10.1002/art.10467 1:CAS:528:DC%2BD38XmvFOqtLw%3D
9. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315-24 3358796 1:STN:280:BieC1M3nt1Q%3D
10. DT Felson JJ Anderson M Boers C Bombardier D Furst C Goldsmith 1995 American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis Arthritis Rheum 38 727-35 7779114 1:STN:280:ByqB1MfgsFI%3D
11. T Pincus JA Summey SA Soraci Jr KA Wallston NP Hummon 1983 Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire Arthritis Rheum 26 1346-53 6639693 1:STN:280:BiuD2M3mt1Q%3D
12. JF Fries DA Bloch JT Sharp DJ McShane P Spitz GB Bluhm 1986 Assessment of radiologic progression in rheumatoid arthritis Arthritis Rheum 29 1-9 3947405 1:STN:280:BimC3s%2Fnslw%3D
13. Y Ichikawa T Shinozawa 1993 Variation of the estimation of radiologic progression in RA (in Japanese) Drug Evaluation Committee of the Japan Rheumatism Foundation Proceedings of the Symposium "New Developments in Drug Evaluation" Ikagakushuppansha Tokyo 23-9
14. K Mikanagi K Nishioka S Sugawara I Nagaya S Yamamoto Y Shiokawa 1991 A prospective long term study of enteric-coated salazosulfapyridine (PJ-306) in rheumatoid arthritis (in Japanese) The Clinical Report 25 1749-65
15. N Nishioka M Nobunaga A Sakuma 1991 A double blind comparative study of 1g/day, 2g/day salazosulfapyridine and placebo in rheumatoid arthritis (in Japanese) Ryumachi 31 327-45 1683015 1:STN:280:By2D2Mrgtl0%3D
16. Physician's Desk Reference. 56th ed. New Jersey: Medical Economics; 2002. p. 1753
17. JS Smolen JR Kalden DL Scott B Rozman TK Kvien A Larsen 1999 Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial Lancet 353 259-66 9929017 10.1016/S0140-6736(98)09403-3 1:CAS:528:DyaK1MXhsF2lsr4%3D
18. DM van der Heijde PL Van Riel IH Nuver-Zwart FW Gribnau LB Van De Putte 1989 Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis Lancet 333 1036-8 10.1016/ S0140-6736(89)92442-2
19. The Australian multicentre clinical trial group 1992 Sulfasalazine in early rheumatoid arthritis J Rheumatol 19 1672-7